Acute Promyelocytic Leukemia Atra
Dec. 27, 2024
Frontiers | Coagulopathy in Acute Promyelocytic Leukemia: Can We Go Beyond Supportive Care? How retinoic acid and arsenic transformed acute promyelocytic leukemia therapy in: Journal of Molecular Endocrinology Volume 69 Issue 4 (2022) RNF8 is responsible for ATRA resistance in variant acute promyelocytic leukemia with GTF2I/RARA fusion, and inhibition of the ubiquitin–proteasome pathway contributes to the reversion of ATRA resistance | Cancer Cell International | Acute Promyelocytic Leukemia Atra